{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:36:19Z","timestamp":1780540579942,"version":"3.54.1"},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2013.49.4.1950147","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:10:48Z","timestamp":1556889048000},"page":"261","source":"Crossref","is-referenced-by-count":7,"title":["Ponatinib for the treatment of chronic myeloid leukemia and\nPhiladelphia chromosome-positive acute lymphoblastic leukemia"],"prefix":"10.3730","volume":"49","author":[{"family":"Narayanan, V.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pollyea, D.A.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gutman, J.A.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jimeno, A.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2013]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:23:40Z","timestamp":1685453020000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dcv2zw"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2013.49.4.1950147","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}